Navigation Links
DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
Date:1/29/2009

will expand its scope to all indications currently treated by radiotherapy and chemotherapy. The ability of siDNA to improve therapeutic efficacy without additional cytotoxicity has potential to extend the market for radiotherapy and chemotherapy. It is anticipated that DNA Therapeutics will have a pipeline with products at different stages of development within the next 5 years, throughout balanced proprietary and partnered programs, thus achieving rapidly significant value creation and providing the exit opportunity for its initial investors.

About SGAM SEFTI

SGAM SEFTI (Specialized European fund for Therapeutic Innovation) is a venture fund dedicated to investments in unlisted French and European companies operating principally in the pharmaceutical field and in medico-surgical applications. The fund acquires interests in the firms which it accompanied through the set-up stage in order to develop and increase the value of innovative therapeutic projects coming mainly from academic research in France, Switzerland and Italy. SGAM SEFTI investment is focused in target companies at an initial stage of development and which have further development opportunities with the potential to provide a capital gain in the medium term through licensing and sale.

    Contacts:

    DNA Therapeutics
    Prof. Jian-Sheng Sun, Ph.D.
    Chairman and CEO
    Phone: +33-624-753-239
    Email: sun@dna-therapeutics.com

    SGAM SEFTI
    Dr. Beatrice Denys, M.D., MBA
    Manager of the fund
    Phone: +33-156-378-712
    Email: Beatrice.denys@sgam.com


'/>"/>
SOURCE DNA Therapeutics SA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
2. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
3. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
4. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
5. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
6. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
7. Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain
8. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
9. Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
10. Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis
11. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014 An experimental drug designed to ... viable first treatment for anemia of inflammation, according to results ... published online today in Blood , the ...   Anemia is a condition that occurs when ... function properly. When an individual has anemia, the body does ...
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces ... is available in its catalogue: ... and Approval of Imported Medical Device ... Edition) http://www.reportlinker.com/p02342770/-Latest-Chinese-Guidebook-for-Application-and-Approval-of-Imported-Medical-Device-Registration-From-Regulations-to-Practices--2014-Edition ... Chinese regulations on medical devices are ...
(Date:8/27/2014)...  Columbia Laboratories, Inc. (Nasdaq: CBRX ) ... clinical trial manufacturing, and advanced analytical and consulting services ... participate at the upcoming Rodman & Renshaw 16 th ... New York . The Company will ... 2014 at the New York Palace Hotel. ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10
... presentation on strategic collaboration opportunities with SRI,s ... a nonprofit pharmaceutical organization and have the ... development capabilities – from "Idea to IND"®. ... preclinical phases of basic research, drug discovery, ...
... 15, 2010 A combination of two devices ... arrest patients each year if implemented nationwide, suggests ... American Heart Association Resuscitation Science Symposium. A significantly ... arrest survived after receiving active compression decompression cardiopulmonary ...
Cached Medicine Technology:SRI International Executive Walter Moos to Discuss Collaborative Pharmaceutical Opportunities with a Nonprofit Organization at BIO-Europe 2010 2SRI International Executive Walter Moos to Discuss Collaborative Pharmaceutical Opportunities with a Nonprofit Organization at BIO-Europe 2010 3NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump™ and ResQPOD® CPR Devices 2NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump™ and ResQPOD® CPR Devices 3
(Date:8/27/2014)... 27, 2014 The extensive polling ... by healthcare research group Black Book Rankings uncovers ... adequately staffed, supplied or built to care for ... initiated this annual survey to gain stakeholder insight ... control, epidemiology and emergency preparedness systems,” said Doug ...
(Date:8/27/2014)... WEDNESDAY, Aug. 27, 2014 (HealthDay News) -- Pouring half a glass ... much, according to a new study. Researchers asked 74 college ... settings and from bottles that had varying amounts of wine in ... normal. Those who had a "rule of thumb" about how ... glass or two fingers from the top -- poured less wine ...
(Date:8/27/2014)... 27, 2014 Connor Sports has ... World Cup in Spain at the Barcelona, Bilbao, Gran ... FIBA Equipment & Venue Centre Partner since 1994 and Official ... six courts will bear the Connor Sports logo and tagline ... globe on the ESPN broadcasts of the FIBA World Cup. ...
(Date:8/27/2014)... TX (PRWEB) August 27, 2014 Picture, if ... not Holmes and Watson but more of a Mr. Inside, ... Davis, in terms of personalities and world view. This Mr. ... University of Texas at Austin, and Mr. Outside was an ... family physician, his new girlfriend, and a gaggle of teenagers ...
(Date:8/27/2014)... NC. SonaCare Medical, LLC, the global ... sales of 15 HIFU devices over the past twelve ... for the company’s ablation technology. , “It is ... achieved over the past year, especially since we are ... our most active sales period,” says Mike Klein, CEO ...
Breaking Medicine News(10 mins):Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 2Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 4Health News:'Half a Glass' Rule May Curb Overdrinking 2Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 2Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 3Health News:UW Rankin Self-Publishes Debut Novel, Sublimity: Perchance to Dream, A Speculative Science Mystery 2Health News:SonaCare Medical Announces Twelve Months Sales Results of Fifteen HIFU Devices 2
... to treat childhood cholera. ,Researchers in Bangladesh have ... effectively with a single dose // of the antibiotic ... The Lancet., ,Cholera is a major global health ... In the resource-limited countries where cholera occurs, any reduction ...
... issue of JAMA says that heart patients who are ... of medications. ,Heart failure affects more than 5 ... States and is associated with a high death rate, ... to reduce the risk of illness and death from ...
... Professor Alice Sigurdson and Colleagues has reported the dosage ... which increases the risk of thyroid cancer. ... were treated for thyroid cancer during their childhood. The ... risk of developing thyroid cancer and there seems to ...
... elevated to the level of health friends. In the same ... to have benefits for coronary heart disease. ,New research ... effect on heart disease and stroke. A research team in ... that drinking a cup of cocoa can prevent potentially fatal ...
... be less at risk from developing the dreaded disease ... the recent issue of Archives of Neurology. ,In ... the course of a MS-like disease in animals, suggesting ... the postpartum period afterward, both states associated with profound ...
... Risk of bone fracture in postmenopausal women might be reduced ... in the September issue of the journal Archives of Internal ... rate of three to five percent per year for about ... high risk for bone fracture, according to background information in ...
Cached Medicine News:Health News:Heart Patients More At Risk Get Fewer Medicines 2Health News:Risk of Thyroid cancer is increased after Childhood Irradiation of Neck region 2Health News:Cocoa: Doesn’t Taste Like Red Wine But Has Benefits Like It 2Health News:Consumption of Soy May Reduce Risk of Fracture in Postmenopausal Women 2
... Uniflex® Nailing System was to develop a ... the widest possible variety of femoral fractures. ... the system takes full advantage of our ... healing combined with modern materials and biomechanical ...
... Quad 4™ Intramedullary Nailing System was to ... used for the widest possible variety of ... were to minimize the number of implants ... system that could address antegrade or retrograde ...
... latest in the Magnes line of biomagnetometer systems, ... full cortical coverage, provides the highest detector density ... of a wide range of neuronal activity. The ... detector configurations and can be equipped with radial ...
... easy voice access to information on the ... easy and intuitive, enabling you to interact ... With the VoiceBox Voice Information Retrieval Software, ... of subjects and topics and receive up-to-date ...
Medicine Products: